|
⚲
|
| Keyboard |
| Brennan Daniel
✚
|
|
|---|---|
| CIK # | 0001657999 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001657999] | |
| 4 | [0001657999] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Catalyst Pharmaceuticals Inc | |
| Brennan Daniel | |
| PDS Biotechnology Corp | |
| Insys Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2019-12-02 | Grant | 44,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2019-12-02 | Grant | 132,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2018-12-19 | Grant | 38,334 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2018-12-19 | Grant | 38,333 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2018-12-19 | Grant | 38,333 | $0.00 | |
|
PDS Biotechnology Corp EDGE
Stock Option (Right To Purchase) · derivative
|
2018-03-01 | Grant | 90,000 | $0.00 | |
|
PDS Biotechnology Corp EDGE
Stock Option (right To Purchase) · derivative
|
2016-11-01 | Grant | 150,000 | $10.09 | 1,513,500 |
|
Insys Therapeutics Inc INSY
Common Stock
|
2016-08-09 | Sell | 5,781 | $19.16 | 110,764 |